{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T13:36:49Z","timestamp":1791293809512,"version":"4.1.0"},"reference-count":70,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","transplantation-proceedings.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.transproceed.2016.11.034","type":"journal-article","created":{"date-parts":[[2017,2,17]],"date-time":"2017-02-17T19:45:41Z","timestamp":1487360741000},"page":"253-259","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Use of Anti-Thymocyte Globulin for Induction Therapy in Cardiac Transplantation: A Review"],"prefix":"10.1016","volume":"49","author":[{"given":"V.","family":"Ruan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.S.C.","family":"Czer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Awad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Kittleson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Arabia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Esmailian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Ramzy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"De Robertis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Trento","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.A.","family":"Kobashigawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2016.11.034_bib1","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.healun.2015.08.003","article-title":"The Registry of the International Society for Heart and Lung Transplantation: Thirty-second Official Adult Heart Transplantation Report\u20132015; Focus Theme: Early Graft Failure","volume":"34","author":"Lund","year":"2015","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.transproceed.2016.11.034_bib2","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0140-6736(98)07493-5","article-title":"Immunosuppressive strategies in transplantation","volume":"353","author":"Denton","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.transproceed.2016.11.034_bib3","doi-asserted-by":"crossref","first-page":"3734","DOI":"10.1161\/01.CIR.0000149745.83186.89","article-title":"Drug therapy in the heart transplant recipient, part I: cardiac rejection and immunosuppressive drugs","volume":"110","author":"Lindenfeld","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.transproceed.2016.11.034_bib4","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.healun.2007.01.002","article-title":"Induction therapy in heart transplantation: is there a role?","volume":"26","author":"Uber","year":"2007","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.transproceed.2016.11.034_bib5","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.healun.2010.05.034","article-title":"The International Society of Heart and Lung Transplantation Guidelines for the Care of Heart Transplant Recipients","volume":"29","author":"Costanzo","year":"2010","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.transproceed.2016.11.034_bib6","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.healun.2008.12.017","article-title":"Report from a consensus conference on the sensitized patient awaiting heart transplantation","volume":"28","author":"Kobashigawa","year":"2009","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.transproceed.2016.11.034_bib7","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/TP.0b013e31823bb664","article-title":"Assessment of batch to batch variation in polyclonal antithymocyte globulin preparations","volume":"93","author":"Popow","year":"2012","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2016.11.034_bib8","doi-asserted-by":"crossref","first-page":"691","DOI":"10.2165\/11315940-000000000-00000","article-title":"Rabbit antithymocyte globulin (thymoglobulin): 25 years and new frontiers in solid organ transplantation and haematology","volume":"70","author":"Gaber","year":"2010","journal-title":"Drugs"},{"key":"10.1016\/j.transproceed.2016.11.034_bib9","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1038\/sj.leu.2404683","article-title":"Mechanisms of action of antithymocyte globulin: T-cell depletion and beyond","volume":"21","author":"Mohty","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.transproceed.2016.11.034_bib10","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1097\/01.tp.0000200305.48244.a6","article-title":"In\u00a0vivo visualization of the effect of polyclonal antithymocyte globulins on the microcirculation after ischemia\/reperfusion in a primate model","volume":"81","author":"Chappell","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2016.11.034_bib11","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S1567-5769(02)00253-9","article-title":"Effects of anti-lymphocytes and anti-thymocytes globulin on human dendritic cells","volume":"3","author":"Monti","year":"2003","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.transproceed.2016.11.034_bib12","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1097\/01.TP.0000164159.20075.16","article-title":"Polyclonal rabbit antithymocyte globulin triggers B-cell and plasma cell apoptosis by multiple pathways","volume":"79","author":"Zand","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2016.11.034_bib13","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1182\/blood.V91.7.2360","article-title":"Induction of Fas (Apo-1, CD95)-mediated apoptosis of activated lymphocytes by polyclonal antithymocyte globulins","volume":"91","author":"Genestier","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.transproceed.2016.11.034_bib14","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/01.TP.0000150210.77543.1B","article-title":"Antithymocyte globulin induces ex\u00a0vivo and in\u00a0vivo depletion of myeloid and plasmacytoid dendritic cells","volume":"79","author":"Fang","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2016.11.034_bib15","doi-asserted-by":"crossref","first-page":"3675","DOI":"10.1182\/blood-2008-01-130146","article-title":"Rabbit ATG but\u00a0not\u00a0horse ATG promotes expansion of functional CD4+CD25highFOXP3+ regulatory T cells in\u00a0vitro","volume":"111","author":"Feng","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.transproceed.2016.11.034_bib16","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1097\/TP.0b013e318166910b","article-title":"Impact of immunosuppressive drugs on CD4+CD25+FOXP3+ regulatory T cells: does in\u00a0vitro evidence translate to the clinical setting?","volume":"85","author":"Demirkiran","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2016.11.034_bib17","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.4049\/jimmunol.167.4.2087","article-title":"Predominance of NK1.1+TCR alpha beta+ or DX5+TCR alpha beta+ T cells in mice conditioned with fractionated lymphoid irradiation protects against graft-versus-host disease: \u201cnatural suppressor\u201d cells","volume":"167","author":"Lan","year":"2001","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.transproceed.2016.11.034_bib18","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1056\/NEJM200003023420902","article-title":"Prevention of rejection in cardiac transplantation by blockade of the interleukin-2 receptor with a monoclonal antibody","volume":"342","author":"Beniaminovitz","year":"2000","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.transproceed.2016.11.034_bib19","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1056\/NEJMoa032953","article-title":"Daclizumab to prevent rejection after cardiac transplantation","volume":"352","author":"Hershberger","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.transproceed.2016.11.034_bib20","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.healun.2015.04.001","article-title":"Induction with anti-thymocyte globulin in heart transplantation is associated with better long-term survival compared with basiliximab","volume":"34","author":"Ansari","year":"2015","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.transproceed.2016.11.034_bib21","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.healun.2007.01.006","article-title":"Basiliximab and rabbit anti-thymocyte globulin for prophylaxis of acute rejection after heart transplantation: a non-inferiority trial","volume":"26","author":"Carrier","year":"2007","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.transproceed.2016.11.034_bib22","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/2047-1440-3-14","article-title":"A\u00a0randomized controlled trial of daclizumab versus anti-thymocyte globulin induction for heart transplantation","volume":"3","author":"Mullen","year":"2014","journal-title":"Transplant Res"},{"key":"10.1016\/j.transproceed.2016.11.034_bib23","first-page":"1","article-title":"Comparison of basiliximab and anti-thymocyte globulin as induction therapy in\u00a0pediatric heart transplantation: a survival analysis","volume":"5","author":"Ansari","year":"2016","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.transproceed.2016.11.034_bib24","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.healun.2004.01.002","article-title":"To induce or not to induce: do patients at greatest risk for fatal rejection benefit from cytolytic induction therapy?","volume":"24","author":"Higgins","year":"2005","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.transproceed.2016.11.034_bib25","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1097\/00007890-200109270-00012","article-title":"Induction versus noninduction in renal transplant recipients with tacrolimus-based immunosuppression","volume":"72","author":"Mourad","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2016.11.034_bib26","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.healun.2003.09.043","article-title":"Use of basiliximab and cyclosporine in heart transplant patients with pre-operative renal dysfunction","volume":"24","author":"Delgado","year":"2005","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.transproceed.2016.11.034_bib27","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/j.healun.2006.09.002","article-title":"Basiliximab versus rabbit anti-thymocyte globulin for induction therapy in patients after heart transplantation","volume":"25","author":"Flaman","year":"2006","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.transproceed.2016.11.034_bib28","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.healun.2003.12.014","article-title":"Induction therapy after cardiac transplantation: a comparison of anti-thymocyte globulin and daclizumab in the prevention of acute rejection","volume":"24","author":"Carlsen","year":"2005","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.transproceed.2016.11.034_bib29","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.healun.2007.05.002","article-title":"Lower risk of infectious deaths in cardiac transplant patients receiving basiliximab versus anti-thymocyte globulin as induction therapy","volume":"26","author":"Mattei","year":"2007","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.transproceed.2016.11.034_bib30","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1016\/j.transproceed.2008.07.113","article-title":"Induction immunosuppression with basiliximab in heart transplantation","volume":"40","author":"Chou","year":"2008","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2016.11.034_bib31","first-page":"CD008842","article-title":"Immunosuppressive T-cell antibody induction for heart transplant recipients","volume":"12","author":"Penninga","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.transproceed.2016.11.034_bib32","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1093\/ndt\/13.9.2322","article-title":"Renal insufficiency after heart transplantation: a case-control study","volume":"13","author":"van Gelder","year":"1998","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.transproceed.2016.11.034_bib33","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1111\/tri.12107","article-title":"Induction therapy in heart transplantation: where are we now?","volume":"26","author":"Aliabadi","year":"2013","journal-title":"Transplant Int"},{"key":"10.1016\/j.transproceed.2016.11.034_bib34","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1097\/01.TP.0000130179.18176.3D","article-title":"Antithymocyte globulin induction allows a prolonged delay in the initiation of cyclosporine in heart transplant patients with postoperative renal dysfunction","volume":"78","author":"Cantarovich","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2016.11.034_bib35","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1016\/j.healun.2016.01.047","article-title":"Calcineurin inhibitor (CNI) delay with ATG induction: teaching an old dog, new tricks","volume":"35","author":"Aliabadi","year":"2016","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.transproceed.2016.11.034_bib36","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1097\/TP.0000000000000950","article-title":"Impact of rabbit antithymocyte globulin dose on long-term outcomes in heart transplant patients","volume":"100","author":"Aliabadi","year":"2016","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2016.11.034_bib37","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1016\/j.transproceed.2013.02.114","article-title":"Antithymocyte globulin induction therapy adjusted for immunologic risk after heart transplantation","volume":"45","author":"Czer","year":"2013","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2016.11.034_bib38","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/S1053-2498(99)00100-X","article-title":"A\u00a010-year experience with intravenous thymoglobuline in induction of immunosuppression following heart transplantation","volume":"18","author":"Carrier","year":"1999","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.transproceed.2016.11.034_bib39","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1161\/01.RES.0000246086.93555.f3","article-title":"Allograft vasculopathy versus atherosclerosis","volume":"99","author":"Rahmani","year":"2006","journal-title":"Circ Res"},{"key":"10.1016\/j.transproceed.2016.11.034_bib40","first-page":"319","article-title":"Cardiac allograft vasculopathy: a review","volume":"48","author":"Ramzy","year":"2005","journal-title":"Can J Surg"},{"key":"10.1016\/j.transproceed.2016.11.034_bib41","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.healun.2006.03.024","article-title":"Ten-year follow-up of a prospective, randomized trial of BT563\/bb10 versus anti-thymocyte globulin as induction therapy after heart transplantation","volume":"25","author":"Bonaros","year":"2006","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.transproceed.2016.11.034_bib42","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.healun.2008.02.016","article-title":"Delayed onset of cardiac allograft vasculopathy by induction therapy using anti-thymocyte globulin","volume":"27","author":"Zhang","year":"2008","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.transproceed.2016.11.034_bib43","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S1053-2498(00)00414-9","article-title":"Low incidence of graft arteriosclerosis after cardiac transplantation - risk factor analysis for patients with induction therapy","volume":"20","author":"Zuckermann","year":"2001","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.transproceed.2016.11.034_bib44","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.jcmg.2013.03.001","article-title":"Detection and imaging of cardiac allograft vasculopathy","volume":"6","author":"Pollack","year":"2013","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.transproceed.2016.11.034_bib45","doi-asserted-by":"crossref","first-page":"e002252","DOI":"10.1161\/CIRCHEARTFAILURE.115.002252","article-title":"Induction therapy with antithymocyte globulin in patients undergoing cardiac transplantation is associated with decreased coronary plaque progression as assessed by intravascular ultrasound","volume":"9","author":"Azarbal","year":"2016","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.transproceed.2016.11.034_bib46","doi-asserted-by":"crossref","first-page":"4217","DOI":"10.1016\/S0041-1345(98)01397-9","article-title":"The nature of ischemia\/reperfusion injury","volume":"30","author":"Massberg","year":"1998","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2016.11.034_bib47","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1161\/CIRCULATIONAHA.107.711911","article-title":"Cardiac allograft vasculopathy: recent developments","volume":"117","author":"Schmauss","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.transproceed.2016.11.034_bib48","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/00007890-199507150-00018","article-title":"Endothelial loss and regeneration in a model of transplant arteriosclerosis","volume":"60","author":"Gohra","year":"1995","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2016.11.034_bib49","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1016\/j.transproceed.2013.02.118","article-title":"A\u00a0novel mechanism of anti-T-lymphocyte globulin mediated by fractalkine in renal ischemia-reperfusion injury in rats","volume":"45","author":"Gunay","year":"2013","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2016.11.034_bib50","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.surg.2012.03.001","article-title":"Treatment with antithymocyte globulin ameliorates intestinal ischemia and reperfusion injury in mice","volume":"152","author":"Watson","year":"2012","journal-title":"Surgery"},{"key":"10.1016\/j.transproceed.2016.11.034_bib51","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1432-2277.2004.tb00469.x","article-title":"Polyclonal anti-thymocyte globulins influence apoptosis in reperfused tissues after ischaemia in a non-human primate model","volume":"17","author":"Beiras-Fernandez","year":"2004","journal-title":"Transplant Int"},{"key":"10.1016\/j.transproceed.2016.11.034_bib52","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.trim.2008.11.004","article-title":"Impact of polyclonal anti-thymocyte globulins on the expression of adhesion and inflammation molecules after ischemia-reperfusion injury","volume":"20","author":"Beiras-Fernandez","year":"2009","journal-title":"Transplant Immunol"},{"key":"10.1016\/j.transproceed.2016.11.034_bib53","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1016\/j.transproceed.2009.11.038","article-title":"Influence of polyclonal antithymocyte globulins on the expression of adhesion molecules of isolated human umbilical vein endothelial cells","volume":"42","author":"Walther","year":"2010","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2016.11.034_bib54","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1097\/01.TP.0000053198.99206.E6","article-title":"Functional antibodies to leukocyte adhesion molecules in antithymocyte globulins","volume":"75","author":"Michallet","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2016.11.034_bib55","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/j.1399-0012.2005.00375.x","article-title":"Thymoglobulin induction protects liver allografts from ischemia\/reperfusion injury","volume":"19","author":"Bogetti","year":"2005","journal-title":"Clin Transplant"},{"key":"10.1016\/j.transproceed.2016.11.034_bib56","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1016\/S0735-1097(16)31453-X","article-title":"Anti-thymocyte globulin protects against ischemia reperfusion injury in the immediate post heart transplant period","volume":"67","author":"Zarrini","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.transproceed.2016.11.034_bib57","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1111\/j.1600-6143.2007.01991.x","article-title":"C4d fixing, luminex binding antibodies: a new tool for prediction of graft failure after heart transplantation","volume":"7","author":"Smith","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2016.11.034_bib58","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1097\/00007890-200010150-00011","article-title":"Flow cytometric detection of HLA-specific antibodies as a predictor of heart allograft rejection","volume":"70","author":"Tambur","year":"2000","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2016.11.034_bib59","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1097\/00007890-199901270-00012","article-title":"The role of flow cytometry-detected IgG and IgM anti-donor antibodies in cardiac allograft recipients","volume":"67","author":"Przybylowski","year":"1999","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2016.11.034_bib60","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.humimm.2010.10.013","article-title":"Pre- and posttransplantation allosensitization in heart allograft recipients: major impact of de novo alloantibody production on allograft survival","volume":"72","author":"Ho","year":"2011","journal-title":"Hum Immunol"},{"key":"10.1016\/j.transproceed.2016.11.034_bib61","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/j.1600-6143.2010.03383.x","article-title":"De novo donor HLA-specific antibodies after heart transplantation are an independent predictor of poor patient survival","volume":"11","author":"Smith","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2016.11.034_bib62","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1097\/TP.0000000000000031","article-title":"Antithymocyte globulin is associated with a lower incidence of de novo donor-specific antibodies in moderately sensitized renal transplant recipients","volume":"97","author":"Brokhof","year":"2014","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2016.11.034_bib63","doi-asserted-by":"crossref","first-page":"3570","DOI":"10.1016\/j.transproceed.2014.08.042","article-title":"Anti-thymocyte gamma-globulin may prevent antibody production after heart transplantation","volume":"46","author":"Rafiei","year":"2014","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2016.11.034_bib64","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.healun.2011.01.716","article-title":"Antithymocyte globulin induction therapy for adult heart transplantation: a UK national study","volume":"30","author":"Emin","year":"2011","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.transproceed.2016.11.034_bib65","doi-asserted-by":"crossref","first-page":"E450","DOI":"10.1111\/ctr.12021","article-title":"The role of thymoglobulin induction in kidney transplantation: an update","volume":"26","author":"Mourad","year":"2012","journal-title":"Clin Transplant"},{"key":"10.1016\/j.transproceed.2016.11.034_bib66","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1600-6143.2004.00692.x","article-title":"Canadian Society of Transplantation consensus workshop on cytomegalovirus management in solid organ transplantation final report","volume":"5","author":"Preiksaitis","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2016.11.034_bib67","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1001\/jama.2011.1592","article-title":"Spectrum of cancer risk among US solid organ transplant recipients","volume":"306","author":"Engels","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.transproceed.2016.11.034_bib68","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.healun.2010.09.005","article-title":"Infection and\u00a0malignancy after pediatric heart transplantation: the role of induction therapy","volume":"30","author":"Gajarski","year":"2011","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.transproceed.2016.11.034_bib69","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1046\/j.1600-6143.2003.00325.x","article-title":"Lymphomas after solid organ transplantation: a collaborative transplant study report","volume":"4","author":"Opelz","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2016.11.034_bib70","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1111\/j.1432-2277.2005.00203.x","article-title":"Incidence and prognosis of cancer following heart transplantation using RATG induction therapy","volume":"18","author":"El-Hamamsy","year":"2005","journal-title":"Transplant Int"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134516309356?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134516309356?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,2]],"date-time":"2020-10-02T17:07:02Z","timestamp":1601658422000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134516309356"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":70,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S0041134516309356"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2016.11.034","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of Anti-Thymocyte Globulin for Induction Therapy in Cardiac Transplantation: A Review","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2016.11.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}